Antibodies to Ro and La

Area of Science:

• Immunology
• Rheumatology
• Autoimmune Diseases

Background:

• Precipitating autoantibodies to Ro and La are observed in a significant portion of patients with systemic lupus erythematosus (SLE) and primary Sjögren's syndrome (SS).
• These autoantibodies are nearly universally present in patients with overlapping SLE and SS.
• Anti-Ro and anti-La antibodies can precede the clinical manifestation of autoimmune diseases by many years.

Purpose of the Study:

• To investigate the prevalence and significance of anti-Ro and anti-La autoantibodies in SLE and SS.
• To explore the potential pathogenic role of these autoantibodies in the clinical expression of SLE and SS.
• To understand the implications of these autoantibodies in the context of neonatal lupus.

Main Methods:

• Serological testing for precipitating autoantibodies (anti-Ro and anti-La).
• Clinical assessment of patients diagnosed with SLE, SS, and overlap syndromes.
• Review of cases involving neonatal lupus and maternal autoantibody status.

Main Results:

• Anti-Ro antibodies are found in nearly 50% of SLE patients and 60-80% of SS patients.
• Anti-La antibodies are present in about 20% of SLE patients and 40-60% of SS patients.
• Maternal anti-Ro/La antibodies are associated with neonatal lupus, including dermatitis and congenital heart block.

Conclusions:

• Anti-Ro and anti-La autoantibodies are key biomarkers in SLE and SS, often appearing years before diagnosis.
• These autoantibodies likely play a pathogenic role in specific clinical manifestations of SLE and SS, including neonatal lupus.
• Further research into these autoantibodies will enhance understanding of SLE and SS etiopathogenesis.